MORRIS PLAINS, N.J., Sept. 4, 2013 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that the Company will present at Stifel Healthcare Conference 2013 on Wednesday, September 11th at 4:25 pm Eastern time at the Four Season Hotel in Boston, Massachusetts. The presentation, which provides a corporate overview, can be downloaded simultaneously at www.immunomedics.com/pdfs/company-presentation.pdf.
Help employers find you! Check out all the jobs and post your resume.
